tesamorelin cjc-1295 no dac ipamorelin 12mg blend + 6mg Research Peptide 1295 (Mod GRF 1 Tesamorelin Ipamorelin CJC-1295 6/3/3 mg

Mechanism of Action Ipamorelin is a selective GHSR-1a agonist

The concentration printed on a label from an unregulated source is not verified

Injectable healing protocol: 23 mg daily (upper end of range), systemic injection - not into the wound itself - daily until the wound resolves, plus 12 weeks maintenance Topical healing protocol: 2 %4 % in a wound-appropriate vehicle applied 23 times daily to wound margins (never into an open, actively bleeding wound) under clinician supervision Stacking: GHK-Cu pairs exceptionally well with BPC-157 and TB-500 - the so-called GLOW stack - for complex healing cases

Folate is required for DNA synthesis in the bone marrow, so impaired methylation can lead to enlarged, dysfunctional red blood cells (macrocytic anemia)